No Data
No Data
HK stock market anomaly: Genscript Bio (01548) once fell more than 7%, releasing Legend Biotech from merger, with impressive clinical data from competing companies.
genscript bio (01548) once fell more than 7%, as of the time of publication, it dropped by 6.34%, closing at 10.94 Hong Kong dollars, with a turnover of 0.235 billion Hong Kong dollars.
Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
Earnings Preview: LEGN to Report Financial Results Pre-market on November 12
Express News | U.S.-Listed Shares of Chinese Firms Drop Premarket on Worries Over Growing U.S.-China Trade Tensions Under Trump Presidency
Genscript Bio (01548): Legend Biotech announces the latest data on the minimal residual disease (MRD) negativity rate related to the Phase 3 CARTITUDE-4 trial.
Genscript Bio(01548) announced that legend biotech will showcase...
Legend Biotech's CARVYKTI Shows Promising Myeloma Results